A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-To-Severe Rheumatoid Arthritis
figureposted on 2020-11-25, 20:02 authored by Christopher J. Edwards, Ruta Sawant, Vishvas Garg, Ella X. Du, Alan Friedman, Keith A. Betts
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.